SOME OF INDIA’S major metropolitan cities have for years provided healthcare services to patients from Africa, the Middle East, Sri Lanka, Maldives, Central Asia, Africa, Bangladesh, south-east Asia, Myanmar, Nepal, and Bhutan, among others.
While Chennai, Mumbai, Delhi, Bengaluru, Hyderabad, and Kolkata have become thriving healthcare hubs, in case of pharmaceutical manufacturing, the journey has been long. Once known as the pharmacy of the Global South, the Covid-19 pandemic provided India an opportunity to emerge as a full-fledged healthcare engine built for scale.
Two of the most widely used vaccines during the pandemic, Covishield and Covaxin, were made in India, with Serum Institute of India’s Covishield earning the moniker “vaccine for the world.” This built a case for India becoming the world’s healthcare powerhouse on the lines of Singapore (Asia’s top…